← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2016Last known activity
Sep 25, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (5 own, 0 via acquisition)
Phase 2 (2 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (11)
- NCT06091410Overall official - principal investigatorPhase 4Sep 25, 2023
- NCT06091410Lead sponsorPhase 4Sep 25, 2023
- NCT05970887Lead sponsorPhase 4Oct 12, 2022
- NCT05970887Overall official - principal investigatorPhase 4Oct 12, 2022
- NCT05970887Reponsible party - principal investigatorPhase 4Oct 12, 2022
- NCT05359224CollaboratorPhase 4Jun 13, 2022
- NCT03625050CollaboratorPhase 2Sep 1, 2018
- NCT03109951Lead sponsorN/AMar 25, 2017
- NCT03109951Reponsible party - principal investigatorN/AMar 25, 2017
- NCT03109951Overall official - principal investigatorN/AMar 25, 2017
- NCT02858856CollaboratorN/ASep 1, 2016
Details
- Last known activity
- Sep 25, 2023